Welcome to the Phreesia Second Quarter Fiscal 2025 Earnings Conference Call
Date: September 4, 2024
Time: 5:00 PM ET
Company Participants:
Balaji Gandhi – Chief Financial Officer
Chaim Indig – Chief Executive Officer
Good evening, ladies and gentlemen, and welcome to the Phreesia Second Quarter Fiscal 2025 Earnings Conference Call. At this time all participants are in a listen-only mode.
During the conference call, the Chief Financial Officer, Balaji Gandhi, and the Chief Executive Officer, Chaim Indig, will be discussing the financial results and performance of Phreesia for the second quarter of fiscal 2025. We will also hear from various conference call participants who will provide insights and analysis on Phreesia’s performance.
Conference Call Participants:
- Anne Samuel – JPMorgan
- Ryan Daniels – William Blair
- Scott Schoenhaus – KeyBanc
- Jessica Tassan – Piper Sandler
- Jailendra Singh – Truist Securities
- Glen Santangelo – Jefferies
- Stephanie Davis – Barclays
- Joe Vruwink – Baird
- John Ransom – Raymond James
- Richard Close – Canaccord Security
- Daniel Grosslight – Citi
- Sean Dodge – RBC Capital Markets
- Jeff Garro – Stephens
- Matthew Shea – Needham & Company
- Jack Wallace – Guggenheim
- Aaron Kimson – Citizens JMP
Overall, this conference call aims to provide investors, stakeholders, and the public with a comprehensive review of Phreesia’s financial performance and strategic outlook for the future. It is an opportunity for transparency and communication between the company and its key stakeholders.
Effect on Me:
As an investor in Phreesia, the insights and analysis provided during this earnings conference call are crucial for making informed decisions about my investment in the company. Understanding the financial performance and strategic direction of Phreesia will help me assess the potential risks and opportunities associated with my investment.
Effect on the World:
Phreesia’s financial performance and strategic outlook have the potential to impact the broader healthcare industry and the technology sector. As a leading provider of healthcare technology solutions, Phreesia plays a significant role in improving patient care and streamlining administrative processes in healthcare facilities. The company’s success can drive innovation and efficiency in the healthcare industry, ultimately benefiting patients and healthcare providers worldwide.
Conclusion:
The Phreesia Second Quarter Fiscal 2025 Earnings Conference Call provides valuable insights into the company’s financial performance and strategic direction. As investors and stakeholders, it is important to closely follow these updates to make informed decisions about our investments and understand the broader impact of Phreesia’s success on the healthcare industry and the world.
